11.07.2015 Views

2DkcTXceO

2DkcTXceO

2DkcTXceO

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A.S. Whittemore 403Venter, D.J., West, D., Whittemore, A.S., Seminara, D. and the BreastCancer Family Registry (2004). The Breast Cancer Family Registry: aninfrastructure for cooperative multinational, interdisciplinary and translationalstudies of the genetic epidemiology of breast cancer. Breast CancerResearch, 6:R375–89.Kalbfleisch, J.D. and Lawless, J.F. (1998). Likelihood analysis of multi-statemodels for disease incidence and mortality. Statistics in Medicine, 7:140–160.Kalbfleisch, J.D. and Prentice, R.L. (2002). The Statistical Analysis of FailureTime Data, 2nd edition. Wiley, New York.Luo, J., Horn, K., Ockene, J.K., Simon, M.S., Stefanick, M.L., Tong, E.,and Margolis, K.L. (2011). Interaction between smoking and obesity andthe risk of developing breast cancer among postmenopausal women: TheWomen’s Health Initiative Observational Study. American Journal ofEpidemiology, 174:919–928.Murphy, A.H. (1973). A new vector partition of the probability score. Journalof Applied Meteorology, 12:595–600.Pepe, M.S. (2003). The Statistical Evaluation of Medical Tests for Classificationand Prediction. Oxford University Press, Oxford.Pepe, M.S. and Cai, T. (2004).The analysis of placement values for evaluatingdiscriminatory measures. Biometrics, 60:528–535.Pepe, M.S., Gu, J.W., and Morris, D.E. (2010). The potential of genes andother markers to inform about risk. Cancer Epidemiology, Biomarkers &Prevention, 19:655–665.Pepe, M.S. and Janes, H.E. (2008). Gauging the performance of SNPs,biomarkers, and clinical factors for predicting risk of breast cancer. Journalof the National Cancer Institute, 100:978–979.Pepe, M.S. and Longton, G. (2005). Standardizing diagnostic markers toevaluate and compare their performance. Epidemiology, 16:598–603.Plevritis, S.K., Kurian, A.W., Sigal, B.M., Daniel, B.L., Ikeda, D.M., Stockdale,F.E., and Garber, A.M. (2006). Cost-effectiveness of screeningBRCA1/2 mutation carriers with breast magnetic resonance imaging.Journal of the American Medical Association, 295:2374–2384.Prentice, R.L. (1986). A case-cohort design for epidemiologic cohort studiesand disease prevention trials. Biometrika, 73:1–11.Putter, H., Fiocco, M., and Geskus, R.B. (2007). Tutorial in biostatistics:Competing risks and multistate models. Statistics in Medicine, 26:2389–2430.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!